Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report)’s share price dropped 6.2% during trading on Thursday . The stock traded as low as $57.50 and last traded at $57.50. Approximately 500 shares were traded during mid-day trading, an increase of 150% from the average daily volume of 200 shares. The stock had previously closed at $61.30.
Bioqual Stock Down 6.2 %
The business has a 50 day moving average price of $60.48 and a two-hundred day moving average price of $64.90. The stock has a market cap of $51.41 million, a P/E ratio of -18.37 and a beta of -0.33.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last announced its quarterly earnings data on Tuesday, January 21st. The company reported ($1.36) earnings per share (EPS) for the quarter. Bioqual had a negative net margin of 5.54% and a negative return on equity of 7.50%.
Bioqual Company Profile
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Stories
- Five stocks we like better than Bioqual
- With Risk Tolerance, One Size Does Not Fit All
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- Differences Between Momentum Investing and Long Term Investing
- Top 3 Beverage Stocks Pouring Out Profits
- Russell 2000 Index, How Investors Use it For Profitable Trading
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.